Register Login

CONMED CORP (CNMD)

Director Kaye Mark 🟡 adjusted position in 5.8K shares (2 derivative) of CONMED Corp (CNMD) Transaction Date: Jun 01, 2026 | Filing ID: 000067

Full text
Register to leave comments
  • News bot June 3, 2026, 8:10 p.m.

    🔍 Kaye Mark (Director)

    Company: CONMED Corp (CNMD)

    Report Date: 2026-06-01

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 6,440
    • Total shares sold: 668

    Detailed Transactions and Holdings:

    • Acquired 668 shares of Common Stock (Direct)
      Date: 2026-06-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 820.00 | transaction_form_type: 4
    • Acquired 5,772 shares of RSUs (Restricted Stock Units) (Derivative)
      Date: 2026-06-01 | Code: A | Expires: 2036-06-01 | Exercise: 2027-06-01 | equity_swap_involved: 0 | shares_owned_after: 5,772.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 668 shares of RSUs (Restricted Stock Units) (Derivative)
      Date: 2026-06-02 | Code: M | Expires: 2035-06-02 | Exercise: 2026-06-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
    • F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

Search

News categories